This content is machine translated Mamma Screening Between statistics and casuistry Once again, a health policy bombshell has burst in the Sunday press. The Swiss Medical Board questions systematic breast screening. As was to be expected, the tsunami of outrage arrived…
View Post 4 min This content is machine translated Highlights of the symposium at the Inselspital Bern How to respond to cervical cancer in pregnancy? The twelfth annual symposium of the Breast and Tumor Center at the Inselspital Bern, which was held at the end of December 2013, focused this time on cervical carcinoma. What…
View Post 3 min This content is machine translated Recurrent ovarian cancer Current developments give hope for a personalized approach At the ESMO Congress in Amsterdam, a review was given of the options available to date in the treatment of recurrent ovarian cancer. Therapy depends on the particular form of…
View Post 6 min This content is machine translated Non-Hodgkin's lymphoma and myelodysplastic syndrome What are the benefits of lenalidomide and pomalidomide? At the ASH Congress in New Orleans, the focus was on the efficacy and safety of lenalidomide plus low-dose dexamethasone in the treatment of patients with newly diagnosed multiple myeloma.…
View Post 4 min This content is machine translated Mistletoe Findings on efficacy from cohort studies The randomized, placebo-controlled trial has become the gold standard of medical research today. This development has been accompanied by an ever-increasing emphasis on evidence-based medicine in curricula and guidelines, increasing…
View Post 4 min This content is machine translated Metastatic renal cell carcinoma. What are the reasons for resistance to current drugs? Practical strategies for treatment management of metastatic renal cell carcinoma (mRCC) were presented at the ESMO Congress in Amsterdam. Updates on current clinical trials and the utility of new treatment…
View Post 5 min This content is machine translated New drugs Optimal use of kinase inhibitors How can kinase inhibitors be put to good use? What are the advantages or disadvantages of a combination? How can genomic sequencing contribute to an individualized therapeutic approach with such…
View Post 5 min This content is machine translated Barrett's esophagus and adenocarcinoma of the esophagus. Mucosal resection and radiofrequency ablation show very good long-term results Intestinal metaplasia, a so-called Barrette epithelium, can develop from normal esophageal squamous epithelium due to various factors. This may develop into low-grade or high-grade dysplasia, which in turn may be…
View Post 5 min This content is machine translated Pancreatic adenocarcinoma The “borderline resectable” tumors as a specific challenge. At ASCO-GI in San Francisco, one of the topics was pancreatic adenocarcinoma. The so-called “borderline resectable” tumors were of particular interest. It is up for discussion whether primary surgery is…
View Post 6 min This content is machine translated Chronic lymphocytic leukemia and non-Hodgkin's lymphoma Updates on the active ingredients GA101 and rituximab Three studies on chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma were discussed at the ASH in New Orleans: One was an update on the stage 1 analysis of the CLL11…
View Post 4 min This content is machine translated Treatment of metastatic colorectal carcinoma. Patients with RAS wild type benefit in overall survival New data on first-line treatment of metastatic colorectal cancer were presented at the ASCO GI in San Francisco. The post-hoc analyses consistently confirm that RAS mutation status is an important…
